Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 4.660
-0.140 (-2.92%)
Nov 13, 2026, 3:04 PM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 436.07M CNY in the quarter ending September 30, 2026, a decrease of -42.44%. This brings the company's total for the last twelve months to 2.10B, down -27.95% year-over-year. In the year 2025, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.78B, down -6.33%. That makes Shanxi Zhendong Pharmaceutical Co.,Ltd the 14,219th largest company in the world by revenue and 2,530th in China.
Revenue (ttm)
2.10B
Revenue Growth
-27.95%
P/S Ratio
2.24
Revenue / Employee
568.64K
Employees
3,695
Market Cap
4.62B
Revenue by Segment
- Pharmaceutical Production and Sales 3.20B 76.7%
- Chinese Herbal Medicine Cultivation 865.38M 20.7%
- Research and Development 104.94M 2.5%
Fiscal year ended Dec 31, 2025 See the full SHE:300158 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.78B | -188.07M | -6.33% |
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.